Roche Venture Fund Parent: Roche
A corporate venture fund of Roche, it makes investments in life science companies aiming to create value by fostering innovation, guiding successful businesses, and generating a financial return for Roche. Roche Venture Fund is looking for private companies with innovative medicines, diagnostics, and technologies. In select cases, it will invest in companies alongside research and development collaborations with Roche or Genentech. For therapeutics, the Fund prefers investing in preclinical companies, and for diagnostics - it prefers 12-18 months to launch. In most cases, the Fund will make and/or participate in Series A investments. In addition to its team in Switzerland, Roche Venture Fund also has an office in San Francisco. Primary contact
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
CH-4070 Basel
Switzerland
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
CH-4070 Basel
Switzerland
Key people ๐งโ๐คโ๐ง
- Carole Nuechterlein - Head of the Fund
- Simon Greenwood - Senior Investment Director
- Monique Schiersing - Senior Investment Director
- David Evans - Investment Director
- Nisha Marathe - Investment Director
- Gabriella Zรถch - Project Manager
- Saoussen Ben Halima, PhD - Principal
Investments ๐ธ
DiogenX
Biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes
๐ Marsille, France
Biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes
๐ Marsille, France
Last update: November 1, 2022
Disclaimer: We can not guarantee that the information on this page is 100% correct. more



